Divine Skin Initiated at Outperform by Zacks Investment Research

Jun 14, 2010, 09:00 ET from Divine Skin Inc.

MIAMI BEACH, Fla., June 14 /PRNewswire-FirstCall/ -- DIVINE SKIN INC. (OTC Bulletin Board: DSKX), a newly public cosmeceutical developer specializing in topical skin care and hair regrowth, announced that Zacks Investment Research had initiated coverage of the company with an "outperform" recommendation and a six-month target price of $0.50, covered by Analyst Claudio Freitas, CFA.

Divine Skin grew quickly without investment capital until 2009, when it conducted its first private placement. It began trading May 20th, 2010.

The company's strategy is to combine active ingredients that already have US Food and Drug Administration monographs, thus avoiding lengthy approvals while achieving efficacy and delivering new products quickly. The company's first brand, DS Laboratories, established itself with comprehensive minoxidil-based and minoxidil-free products.

Last week, DS Laboratories announced a new agreement for its DS Laboratories brand to supply hair-growth products through Premier Salons, one of North America's largest chains, with about 3,000 locations. It also announced the distribution of its DS Laboratories brand to Fantastic Sams chain, with more than 1,300 franchised salons locations in the United States. So far demand has exceeded expectations.

The full report can be viewed at: http://www.proactivenewsroom.com/ds-laboratories-inc

About Zacks

Founded in 1978 in Chicago, Zacks Investment Research, Inc. is one of the largest independent investment research and consulting firms in the United States. With 30 years of experience, dedicated to the highest standards of services, Zacks has become an industry leader in providing institutional and individual investors with the analytical tools and financial information necessary to succeed.  

About Divine Skin

Divine Skin Inc. develops, markets, and distributes personal-care products through cosmetics wholesalers, online retailers, specialty outlets, spas, salons, and medical offices in more than 20 countries. Its cosmeceutical brands include DS Laboratories, Sigma Skin, and Polaris Research.

DS Laboratories, the flagship brand, offers high-performance topical solutions for men and women to restore growth and radiance to hair; suppress dandruff and unwanted hair; control acne; maintain feminine hygiene; and reduce the appearance of cellulite, wrinkles, and double chins (www.dslaboratories.com).

The Sigma Skin brand targets men and sells through upscale retailers like Bergdorf Goodman in the United States, Saks Fifth Avenue in Mexico, and Harvey Nichols in the United Kingdom. Products are designed to reverse hair loss and other signs of aging (www.sigmaskin.com).

Polaris Research makes high-potency minoxidil-based hair-growth formulas (www.polarisresearch.co.uk).

Divine Skin's management believes the company has established itself as a leader in topical therapies, especially hair-growth, through aggressive pursuit of innovation and technology. Products employ comprehensive formulas with multiple methods of action against common skin conditions. Many utilize proprietary encapsulation techniques for improved bioavailability.

SOURCE Divine Skin Inc.